| GlaxoSmithKline AG - Zovirax i.v., Pulver zur Herstellung einer Infusionslösung |
| 44772 | | 01 | | Zovirax i.v. | | Pulver zur Herstellung einer Infusionslösung | | J05AB01 | | Aciclovir | | 23.08.1982 | | |
|
| Composition |
| Praeparatio cryodesiccata: aciclovirum 250 mg ut natrii hydroxidum, pro vitro corresp. natrium 23.74-28.02 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Aciclovir | 250 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 019 | 5 ampoule(s) | | | A | | No |
|
